Gender differences relating to metabolic syndrome and proinflammation in finnish subjects with elevated blood pressure

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Ahonen, Tiina ^a   Saltevo, Juha ^b   Laakso, Markku ^c   Kautiainen, Hannu ^b,d   Kumpusalo, Esko ^c,e   Vanhala, Mauno ^b,c  

^a Palokka Health Center   (Finland)

^b Central Finland Central Hospital   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Orton Hospital   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; INTERLEUKIN 1BETA;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SEX DIFFERENCE; BLOOD; FINLAND; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; FINLAND; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; SEX FACTORS;

EID: 69249214038     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/959281     Document Type: Article

References (43)

1. Ferrannini E., Buzzigoli G., Bonadonna R., Insulin resistance in essential hypertension The New England Journal of Medicine 1987 317 6 350 357
2. Pollare T., Lithell H., Berne C., Insulin resistance is a characteristic feature of primary hypertension independent of obesity Metabolism 1990 39 2 167 174
3. Swislocki A. L. M., Hoffman B. B., Reaven G. M., Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension American Journal of Hypertension 1989 2 6 419 423
4. Ferrannini E., Haffner S. M., Mitchell B. D., Stern M. P., Hyperinsulinaemia: the key feature of cardiovascular and metabolic syndrome Diabetologia 1991 34 6 416 422
5. Reaven G. M., Banting lecture 1988. Role of insulin resistance in human disease Diabetes 1988 37 12 1595 1607
6. Ford E. S., Kohl H. W. III, Mokdad A. H., Ajani U. A., Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults Obesity Research 2005 13 3 608 614
7. Lakka T. A., Laaksonen D. E., Lakka H.-M., Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome Medicine and Science in Sports and Exercise 2003 35 8 1279 1286
8. Rennie K. L., McCarthy N., Yazdgerdi S., Marmot M., Brunner E., Association of the metabolic syndrome with both vigorous and moderate physical activity International Journal of Epidemiology 2003 32 4 600 606
9. Holme I., Tonstad S., Sogaard A. J., Larsen P. G. L., Hheim L. L., Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study BMC Public Health 2007 7, article 154
10. Wada T., Urashima M., Fukumoto T., Risk of metabolic syndrome persists twenty years after the cessation of smoking Internal Medicine 2007 46 14 1079 1082
11. Yokoyama H., Hiroshi H., Ohgo H., Hibi T., Saito I., Effects of excessive ethanol consumption on the diagnosis of the metabolic syndrome using its clinical diagnostic criteria Internal Medicine 2007 46 17 1345 1352
12. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556
13. Nishida M., Funahashi T., Shimomura I., Pathophysiological significance of adiponectin Medical Molecular Morphology 2007 40 2 55 67
14. Ryo M., Nakamura T., Kihara S., Adiponectin as a biomarker of the metabolic syndrome Circulation Journal 2004 68 11 975 981
15. Matsushita K., Tamakoshi K., Yatsuya H., Further inflammatory information on metabolic syndrome by adiponectin evaluation International Journal of Cardiology 2008 124 3 339 344
16. Bautista L. E., Atwood J. E., OMalley P. G., Taylor A. J., Association between C-reactive protein and hypertension in healthy middle-aged men and women Coronary Artery Disease 2004 15 6 331 336
17. Frhlich M., Imhof A., Berg G., Association between C-reactive protein and features of the metabolic syndrome Diabetes Care 2000 23 12 1835 1839
18. Jager J., Grmeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J.-F., Interleukin-1 -induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression Endocrinology 2007 148 1 241 251
19. Dalekos G. N., Elisaf M., Bairaktari E., Tsolas O., Siamopoulos K. C., Increased serum levels of interleukin-1 in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? Journal of Laboratory and Clinical Medicine 1997 129 3 300 308
20. Peeters A. C. T. M., Netea M. G., Janssen M. C. H., Kullberg B. J., Van der Meer J. W. M., Thien T., Pro-inflammatory cytokines in patients with essential hypertension European Journal of Clinical Investigation 2001 31 1 31 36
21. Vanhala M., Kautiainen H., Kumpusalo E., Proinflammation and hypertension: a population-based study Mediators of Inflammation 2008 2008 7
22. Abbatecola A. M., Ferrucci L., Grella R., Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly Journal of the American Geriatrics Society 2004 52 3 399 404
23. Ruotsalainen E., Salmenniemi U., Vauhkonen I., Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects Diabetes Care 2006 29 12 2714 2720
24. Schillaci G., Pirro M., Vaudo G., Prognostic value of the metabolic syndrome in essential hypertension Journal of the American College of Cardiology 2004 43 10 1817 1822
25. Mule G., Nardi E., Cottone S., Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients. Journal of the Cardiometabolic Syndrome 2007 2 2 84 90
26. Schillaci G., Pirro M., Vaudo G., Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension Hypertension 2005 45 6 1078 1082
27. Saltevo J., Vanhala M., Kautiainen H., Kumpusalo E., Laakso M., Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study Diabetic Medicine 2008 25 6 747 750
28. Pischon T., Hu F. B., Rexrode K. M., Girman C. J., Manson J. E., Rimm E. B., Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men Atherosclerosis 2008 197 1 392 399
29. Sciarretta S., Ferrucci A., Ciavarella G. M., Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive pwith metabolic syndrome American Journal of Hypertension 2007 20 7 784 791
30. Schillaci G., Pirro M., Pucci G., Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women Hypertension 2006 47 5 881 886
31. Thorand B., Baumert J., Kolb H., Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 19842002 Diabetes Care 2007 30 4 854 860 (Pubitemid 46556577)
32. Efron B., Tibshirani R., An Introduction to the Bootstrap 1998 New York, NY, USA Chapman and Hall/CRC
33. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nature Reviews Immunology 2006 6 10 772 783
34. Blouin K., Boivin A., Tchernof A., Androgens and body fat distribution Journal of Steroid Biochemistry and Molecular Biology 2008 108 35 272 280
35. You T., Ryan A. S., Nicklas B. J., The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation Journal of Clinical Endocrinology and Metabolism 2004 89 11 5517 5522
36. Juge-Aubry C. E., Somm E., Chicheportiche R., Regulatory effects of interleukin (IL)-1, interferon-, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue The Journal of Clinical Endocrinology Metabolism 2004 89 6 2652 2658
37. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., Dayer J.-M., C-reactive protein increases production of IL-1, IL-1, and TNF-, and expression of mRNA by human alveolar macrophages Journal of Leukocyte Biology 1993 53 4 439 445
38. Snijder M. B., Dekker J. M., Visser M., Prospective relation of C-reactive protein with type 2 diabetes Diabetes Care 2003 26 5 1656 1658
39. Doi Y., Kiyohara Y., Kubo M., Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama study Diabetes Care 2005 28 10 2497 2500
40. Han T. S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M. E. J., Haffner S. M., Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study Diabetes Care 2002 25 11 2016 2021
41. Kashyap S. R., Defronzo R. A., The insulin resistance syndrome: physiological considerations Diabetes and Vascular Disease Research 2007 4 1 13 19
42. Arner P., Insulin resistance in type 2 diabetes: role of fatty acids Diabetes/Metabolism Research and Reviews 2002 18 supplement 2 S5 S9
43. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome The Lancet 2005 365 9468 1415 1428